Home › Smoldering Multiple Myeloma › Texas
Smoldering Multiple Myeloma clinical trials in Texas
4 studies for Smoldering Multiple Myeloma are looking for participants at sites in Texas.
Cities in Texas
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Houston Methodist San Jacinto Hospital, Baytown
- UT MD Anderson - The Woodlands, Conroe
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- and 13 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT02726750Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT05136807Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- UT Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.